EFFECTS OF rHuEPO THERAPY ON EXERCISE CAPACITY IN HEMODIALYSIS PATIENTS WITH CORONARY ARTERY DISEASE

We investigated the effects of recombinant human erythropoietin (rHuEPO) therapy on exercise capacity by symptom-limited maximal treadmill exercise testing in 9 patients with coronary artery disease who were receiving maintenance hemodialysis. The initial hemoglobin concentration of 7.9±0.7g/dl, (me...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	JAPANESE CIRCULATION JOURNAL 1993/05/20, Vol.57(2), pp.131-137
Hauptverfasser:	HASE, HIROKI, IMAMURA, YOSHIHIKO, NAKAMURA, RYOICHI, INISHI, YOJI, MACHII, KIYOSHI, MAGUCHI, TETSUYA
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Anemia - etiology Anemia - prevention & control Biological and medical sciences Blood. Blood coagulation. Reticuloendothelial system Coronary artery disease Coronary Disease - complications Erythropoietin - therapeutic use Exercise Test Exercise-induced ST depression Female Hemodialysis Humans Male Medical sciences Middle Aged Pharmacology. Drug treatments Physical Endurance - drug effects Recombinant human erythropoietin Recombinant Proteins - therapeutic use Renal Dialysis - methods Treadmill exercise testing
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	We investigated the effects of recombinant human erythropoietin (rHuEPO) therapy on exercise capacity by symptom-limited maximal treadmill exercise testing in 9 patients with coronary artery disease who were receiving maintenance hemodialysis. The initial hemoglobin concentration of 7.9±0.7g/dl, (mean±S.D.) rose to 10.4±1.1 g/dl, (p
ISSN:	0047-1828 1347-4839
DOI:	10.1253/jcj.57.131